370893003: Crisantaspase (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Enzyme\Hydrolase\Asparaginase (substance)\Crisantaspase

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Antineoplastic agent (substance)\Asparaginase (substance)\Crisantaspase

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Asparaginase (substance)\Crisantaspase

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Asparaginase (substance)\Crisantaspase

\Biological substance\Protein and/or protein derivative\Protein\Asparaginase (substance)\Crisantaspase
\Biological substance\Polypeptide\Protein\Asparaginase (substance)\Crisantaspase

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Crisantaspase	Is a	Asparaginase (substance)	true	Inferred relationship	Some
Crisantaspase	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Hydrolase (disposition)	true	Inferred relationship	Some
Crisantaspase	Is a	Antineoplastic agent (substance)	false	Inferred relationship	Some
Crisantaspase	Is a	allergène médicamenteux	false	Inferred relationship	Some
Crisantaspase	Is a	agent enzymatique	false	Inferred relationship	Some
Crisantaspase	Is a	Hydrolase	false	Inferred relationship	Some
Crisantaspase	Is a	Protein	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Crisantaspase	Inferred relationship	Some
Product containing crisantaspase (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Crisantaspase	Inferred relationship	Some	1
Crisantaspase poisoning of undetermined intent	Causative agent (attribute)	False	Crisantaspase	Inferred relationship	Some	1
Allergy to crisantaspase (finding)	Causative agent (attribute)	False	Crisantaspase	Inferred relationship	Some
Intentional crisantaspase overdose	Causative agent (attribute)	True	Crisantaspase	Inferred relationship	Some	1
Crisantaspase overdose	Causative agent (attribute)	True	Crisantaspase	Inferred relationship	Some	1
Crisantaspase overdose of undetermined intent	Causative agent (attribute)	False	Crisantaspase	Inferred relationship	Some	1
Accidental crisantaspase poisoning	Causative agent (attribute)	True	Crisantaspase	Inferred relationship	Some	1
Intentional crisantaspase poisoning	Causative agent (attribute)	True	Crisantaspase	Inferred relationship	Some	1
Accidental crisantaspase overdose	Causative agent (attribute)	True	Crisantaspase	Inferred relationship	Some	1
Crisantaspase poisoning	Causative agent (attribute)	True	Crisantaspase	Inferred relationship	Some	1
Allergy to crisantaspase (finding)	Causative agent (attribute)	True	Crisantaspase	Inferred relationship	Some	1
Product containing only crisantaspase (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Crisantaspase	Inferred relationship	Some	1
Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Crisantaspase	Inferred relationship	Some	1
Crisantaspase-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Crisantaspase	Inferred relationship	Some	1
Crisantaspase only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Crisantaspase	Inferred relationship	Some	1
Crisantaspase adverse reaction	Causative agent (attribute)	True	Crisantaspase	Inferred relationship	Some	1
Product containing precisely crisantaspase 10000 unit/1 vial powder for conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Crisantaspase	Inferred relationship	Some	1
Product containing precisely crisantaspase 10000 unit/1 vial powder for conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Crisantaspase	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1209618019	Erwinia asparaginase	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
1228873015	Crisantaspase	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1228874014	Erwinia L-asparaginase	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
3686364014	Crisantaspase (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
5268837012	Asparaginase Dickeya chrysanthemi	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
5268838019	Asparaginase Erwinia chrysanthemi	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
373451000195113	crisantaspasi	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
27031000188111	erwinia asparaginase	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module